drugset / Trial / NCT02273947

Food Effect Study With BMS-955176

NCT02273947

Phase 1 Completed 12 enrolled ViiV Healthcare GlaxoSmithKline · collab
RandomizedCrossoverOpen-labelOther

Summary

The purpose of this study is to assess the impact of a light meal, a standard meal, and a high fat meal on the PK of BMS-955176 MC tablet at a dose of 180 mg, relative to fasted conditions.

Timeline

Start
2014-10-23
Primary completion
2016-08-15
Completion
2016-08-15

Drugs

EvaluationDrugModalityDoseRoute
Subject BMS-955176 Other / unclassified 180 mg Oral